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CD26 immuno-expression and periodontal
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Immunological mechanisms participate in the pathogenesis of human chronic inﬂammatory periodontal disease (CIPD). Human
CD4+ lymphocytesexpressfunctionallyheterogeneousproﬁlesof cytokineproduction.CD26isanintegralmembraneglycoprotein,
thatis,amarkerofTh1-likecytokinedevelopment.Thepurposeofthepresentstudywastocomparetheimmuno-expressionofCD26
receptor in periodontal sites with and without clinical attachment loss (CAL). Five patients with rapidly progressing periodontitis
and one with juvenile periodontitis were investigated. Each patient presented at least one site with and without CAL. Ten sites with
CAL and nine without any CAL were biopsied,followed by the immunohistochemical identiﬁcation of the CD26 receptor using the
MIB-DS2/7 antibody. The results demonstrated that the percentage of positive cells for this antigen in the periodontal sites with
CALwasnotsigniﬁcantlydifferentfromthosewithoutattachmentloss.Therefore,Th1cellimpairmentmaynotbedirectlyinvolved
with periodontal attachment loss.
INTRODUCTION
Immunological mechanisms have been implicated in the
pathogenesis of human chronic inﬂammatory periodontal
disease (CPID)for over 30 years. Defects in polymorphonu-
clear leukocytes [1], depressed cellular immune response
[2, 3], polyclonal β-cell activation [4], and imbalance in the
cytokinenetwork[5–10]aresomeofthealterationsreported.
However,fewstudieshavecomparedimmunologicalfeatures
of active versus nonactive periodontal lesions [11].
Human CD4+ lymphocytes express functionally het-
erogeneous proﬁles of cytokine production [12–14]. Th1
CD4+ produce interleukin-2 (IL-2)and interferon- γ (IFN-
γ), whereas Th2 cells produce mainly interleukins-4 (IL-4)
and 5 (IL-5). The same pattern of cytokine proﬁle has also
been described in CD8+ lymphocytes. The presence of IL-
4 or IL-12 contributes to these highly polarized phenotypes
[13–16]. Some signaling molecules, like Stat4 and Stat6, ap-
pearessentialforTh1andTh2development,respectively.The
Th1 subset induces cell-mediated immune responses, while
the Th2 subset is associated with humoral-type responses.
The study of Th1 and Th2 subsets in inﬂammatory dis-
eases is hampered by the lack of reliable surface markers
for these cell phenotypes. Additionally,human T-cells clones
formacontinuousspectruminwhichTh1andTh2cellsmay
be only two of the possible extreme phenotypes [17]. CD30
was reported to be a marker of the Th2 proﬁle [18], but this
receptor is not strictly limited to Th2 cells [19].
CD26 is an integral type II membrane glycoprotein of
110kDa with a dipeptidyl peptidase IV activity [20,21]. This
receptorisexpressedin10%–60%of peripheralbloodTcells,
and T-cell activation is accompanied by its enhanced expres-
sion[20–22].CD26immunostainingcorrelateswiththepro-
duction of IFN-γ in granulomatous diseases [23] and addi-
tional studies implicated the CD26 receptor as a marker of
Th1-like cytokines development [17, 24].
ToexaminethecellularimmuneresponseandTh1subsets
in human chronic inﬂammatory periodontal disease patho-
genesis, in the present study we investigated the immuno-
expression of CD26 receptor in periodontal sites with and
without clinical attachment loss (CAL).
MATERIALS AND METHODS
Subjects
Six patients with early onset periodontitis (ﬁve affected
with rapidly progressing periodontitis and one with juvenile
periodontitis)were included in this study. They were ini-
tially treated with oral hygiene instructions, scaling and root
planning,as well as plaque index assessment.After six weeks,
monthly evaluations were done over a nine-month period.
The evaluations consisted of probing depth, clinical attach-
ment loss and bleeding on probing measures, using an elec-
tronic controlled-force probe (Florida Probe, Florida Probe
Corporation, Gainesville, and Florida).
Small gingival biopsies were done according to the fol-
lowingcriteria:(a) ≥ 1mmof CALsincethebaselinetherapy
and ≥ 5mm of pocket depth; (b)no CAL after the baseline
measurementbutassociatedwithteethdesignatedforextrac-
tion. The biopsies were performed by incision with approxi-
mately 1.5mm thickness extending from the sulcus outward
through the oral epithelium and apical to the depth of the
periodontal sulcus. Each patient presented at least one site
with and without CAL. Ten sites with CAL and nine with-
out CAL were biopsied. Biopsies from both groups (with and92 P. M. L. Manna et al. 1:2 (2001)
withoutCAL)werematchedasclosestaspossibletotheprob-
ing depth and clinical attachment level at the initial exami-
nation,and supragingival plaque. No patient had a history of
diseaseormedicationswhichmightaffectthemicrobialﬂora,
immunesystemorinﬂammatoryresponse.Informedconsent
was received from each subject and the research project was
approved by the University’s Ethics Committee.
Immunohistochemistry
Although many antibodies speciﬁc for CD26 receptor are
available, not all of them have been found useful in identify-
ing a Th1-like immune reaction in human tissues. Different
antibodies against CD26 receptor were tested for discrimi-
nation between Th1-like and Th2-like reactions in leprosy
[24]. According to these authors,although all seven antibod-
ies used were speciﬁc for this antigen, only the MIB-DS2/7
and2A6werecapabletoidentifyaTh1-likeimmunereaction
inhumandisease.Therefore,inthepresentstudyweusedthe
clone MIB-DS2/7, kindly provided by Dr. Ulrike Seitzer, to
identify the CD26 receptor.
Frozen sections obtained by cryostat (Microm-HM 500
OM)were subjected to the biotin-streptavidin ampliﬁed sys-
tem for CD26 immunostaining. Brieﬂy, the sections were
ﬁxed in cold acetone for 10min and immersed in 3%
methanol-hydrogen peroxide solution for 10min, to block
endogenousperoxidaseactivity.Afterwashingin20mMtris-
HClbuffercontaining0.19MNaCl(pH7.4),thesectionswere
incubated with anti-CD26 (prediluted)in tris- HCl buffer
for 18hours at 4◦C. Thereafter, the sections were washed
once again in tris-HCl buffer (pH 7.4)and incubated at
room temperature with biotinylated rabbit anti-mouse im-
munoglobulin (DAKO)diluted 1:400 in tris- HCl for 30min;
washed with tris-HCl twice for 10min; incubated for an-
other 30min with horseradish peroxidase-conjugated strep-
tavidin (DAKO)prepared according to the manufacturer’s
directions;washedwithtris-HCl;incubatedforthreeminutes
with0.01%diaminobenzidinetetrahydrochloride(DAB)and
0.3% H2O2 intris-HCl buffer(pH7.4);rinsedindistilledwa-
ter for 10min and ﬁnally counterstained with Mayer’s hema-
toxylin. To avoid false positive results, a series of tissue sec-
tions were stained with omission of the primary antibody.
Cellquantiﬁcationandstatisticalanalysis
The immunostaining of CD26 was quantitatively ana-
lyzed at six high-power microscopic ﬁelds at the epithe-
lium/connective tissue interface (400x)through a square mi-
crometer. The deﬁnitions of the ﬁrst microscopic ﬁeld were
established by adjusting the square micrometer at the api-
calinterfaceof theperiodontalpocketepithelium/connective
tissue. The results are expressed as the percentage of positive
cells.
Statisticalanalysis
Sincepercentagevaluesdonotdemonstrateanormaldis-
tribution,anonparametricanalysisWilcoxonsignedranktest
was used to compare the means of the sites with and without
CAL. The error in cell counts was determined by six dou-
ble counts in different moments and was below 2.2% of the
cell-speciﬁc counts.
RESULTS
Some immunostaining was observed in the connective
tissue. The cells immunostained by the antibody MIB-DS2/7
showed a lymphoid morphology. The percentage of CD26+
cells in the periodontal sites with CAL (mean: 10.3, median:
24.6,minimal:1.2,maximal:47.9)wasnotsigniﬁcantlydiffer-
ent from those without it (mean: 6.9,median: 11.0,minimal:
2.1, maximal: 15.1).
DISCUSSION
Cytokines are particularly important for immune system
regulation and T-lymphocytes have a central role in it. Th1
and Th2 cells induce cell-mediated and humoral-type im-
mune responses,respectively [12,24]. Th1 and Th2 lympho-
cytes are a polarized spectrum of T-cell differentiation and
not distinct T-cell clones and their products regulate the dif-
ferentiationandtheeffectorfunctionsofthereciprocalsubset
[13–16]. The deﬁnition of Th1 or Th2 cells is based primar-
ily on the type of cytokines produced. Recently, the CD26
receptor was suggested as a marker of Th1-like cytokine de-
velopment[17,24].Inthepresentstudy,weusedtheantibody
MIB-DS2/7forCD26immunostaining.Thisantibodyisuse-
ful to identify the Th1 cells in inﬂammatory diseases [24].
The regulation of the immune system in human chronic
inﬂammatory periodontal disease has been extensively stud-
ied. Seymour et al. [25] and Gemmell et al. [26] proposed
that the progression of periodontal diseases is characterized
by a shift from a predominantly Th1 to a Th2 cell proﬁle.
This hypothesis is supported by some studies [2, 7, 11, 27–
31] but has not been conﬁrmed by others [32, 33]. Ellis et al.
[10] suggested that progressively lower gingival concentra-
tionsof IL-12andhigherIL-6concentrationsassociatedwith
increasing sulcular depth not only indicates a shift from a
Th1 to a Th2 immunologic phenotype, but also suggests a
regulatory role for IL-12 in that shift. Considering that dif-
ferent methodologies were used in these studies, a deﬁnitive
conclusion about Th1 and Th2 cells and periodontal disease
activity cannot be achieved.
Inthecurrentstudy,wehavenotobservedanydifferences
in CD26 immunostaining between the periodontal sites with
and without CAL. These data suggest that Th1 cell impair-
ment is not directly involved with periodontal attachment
loss. However, we used a longitudinal assay to discriminate
active versus nonactive periodontal sites. The samples in the
active sites were collected after periodontal attachment loss.
Therefore, the possibility that we analyzed a postactive event
cannot be completely ruled-out. Furthermore, the extent of
activeorinactiveperiodsinperiodontaldiseaseisnotknown
[34]. If periodontal pockets have prolonged periods of inac-
tivity plus brief episodes of localized exacerbation, the pro-
tocol used would not discriminate the lesions susceptible to1:2 (2001)CD26 and periodontal disease 93
periodontal breakdown from those which are quiescent. This
could be due to the poor resolution of the available clinical
measurements [35].
Inconclusion,ourstudyshowsthatperiodontalsiteswith
and without attachment loss do not have different numbers
ofTh1cellsandfurtherstudiesarenecessarytoclarifytheim-
portance of Th1 cells in the biological activity of periodontal
disease.
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